Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.38% |
| 2 | Consumer Discretionary | 1.03% |
| 3 | Financials | 0.75% |
| 4 | Healthcare | 0.67% |
| 5 | Communication Services | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11251
PUT
Atossa Therapeutics
ATOS
$26.4M
| $63.1K | ﹤0.01% |
3,533
+1,766
| +100% | +$39.1K |
|
11252
X4 Pharmaceuticals
XFOR
$413M
| $63.1K | ﹤0.01% |
3,624
-13,132
| -78% | -$429K |
|
11253
Reading International Class A
RDI
$44.4M
| $63K | ﹤0.01% |
44,362
-25,977
| -37% | -$42.4K |
|
|
BLRX
11254
PUT
BioLineRX
BLRX
$11.8M
| $63K | ﹤0.01% |
2,763
-1,540
| -36% | -$41.3K |
|
11255
CALL
Smith Micro Software
SMSI
$16.6M
| $63K | ﹤0.01% |
5,700
+4,957
| +667% | +$58.3K |
|
|
INZY
11256
DELISTED
Inozyme Pharma
INZY
| $62.9K | ﹤0.01% |
14,114
-16,040
| -53% | -$77.8K |
|
|
ETWO
11257
PUT
DELISTED
E2open Parent Holdings
ETWO
| $62.9K | ﹤0.01% |
14,000
+500
| +4% | +$2.25K |
|
11258
Sera Prognostics
SERA
$82.4M
| $62.6K | ﹤0.01% |
10,573
-145,534
| -93% | -$1.3M |
|
11259
PUT
Gilat Satellite Networks
GILT
$783M
| $62.6K | ﹤0.01% |
+14,000
| New | +$74.5K |
|
|
CEI
11260
CALL
DELISTED
Camber Energy, Inc
CEI
| $62.4K | ﹤0.01% |
519,800
+10,100
| +2% | +$1.69K |
|
|
SHCR
11261
CALL
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $62.4K | ﹤0.01% |
+46,200
| New | +$38K |
|
|
MAXN
11262
DELISTED
Maxeon Solar Technologies
MAXN
| $62.2K | ﹤0.01% |
729
+454
| +165% | +$96.2K |
|
|
CSCI
11263
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $62.1K | ﹤0.01% |
+13,613
| New | +$104K |
|
11264
AquaBounty Technologies
AQB
$6.64M
| $61.7K | ﹤0.01% |
37,180
+25,272
| +212% | +$46.3K |
|
11265
PUT
Cellectar Biosciences
CLRB
$24M
| $61.5K | ﹤0.01% |
820
+240
| +41% | +$23K |
|
11266
IZEA Worldwide
IZEA
$54.3M
| $61.2K | ﹤0.01% |
26,026
+11,621
| +81% | +$29.8K |
|
|
ME
11267
PUT
DELISTED
23andMe Holding Co
ME
| $61K | ﹤0.01% |
7,820
+3,095
| +66% | +$29.6K |
|
11268
PUT
Precigen
PGEN
$2.66B
| $61K | ﹤0.01% |
38,600
+17,100
| +80% | +$24.8K |
|
|
EFXT
11269
PUT
Enerflex
EFXT
$2.43B
| $60.5K | ﹤0.01% |
+11,200
| New | +$60.8K |
|
|
VNET
11270
PUT
VNET Group
VNET
$1.88B
| $60.1K | ﹤0.01% |
28,600
-101,900
| -78% | -$195K |
|
|
DAO
11271
CALL
Youdao
DAO
$2.03B
| $60K | ﹤0.01% |
15,300
+1,000
| +7% | +$3.76K |
|
11272
CS Disco
LAW
$266M
| $59.9K | ﹤0.01% |
+10,056
| New | +$69.5K |
|
|
LILM
11273
PUT
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $59.9K | ﹤0.01% |
75,800
-31,600
| -29% | -$29.6K |
|
|
DHF
11274
BNY Mellon High Yield Strategies Fund
DHF
$172M
| $59.7K | ﹤0.01% |
24,763
-11,078
| -31% | -$26.3K |
|
11275
PUT
Cardiff Oncology
CRDF
$76.6M
| $59.5K | ﹤0.01% |
26,800
+7,300
| +37% | +$27.5K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2024 filing shows 1,591 new, 4,593 increased, 5,607 reduced and 1,726 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M. The largest sale was NVIDIA, an estimated $5.31B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.